AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 83 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $794,310 | -45.3% | 124,500 | -5.0% | 0.00% | 0.0% |
| Q2 2023 | $1,452,790 | -17.6% | 131,000 | +14.1% | 0.00% | 0.0% |
| Q1 2023 | $1,762,180 | -40.9% | 114,800 | -14.6% | 0.00% | -50.0% |
| Q4 2022 | $2,982,336 | +106.4% | 134,400 | +51.9% | 0.00% | +100.0% |
| Q3 2022 | $1,445,000 | +19.5% | 88,500 | +6.4% | 0.00% | 0.0% |
| Q2 2022 | $1,209,000 | -21.3% | 83,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,537,000 | -14.0% | 83,200 | +10.6% | 0.00% | 0.0% |
| Q4 2021 | $1,788,000 | -3.5% | 75,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,852,000 | +101.5% | 75,200 | +102.2% | 0.00% | 0.0% |
| Q2 2021 | $919,000 | +41.8% | 37,200 | +25.3% | 0.00% | – |
| Q1 2021 | $648,000 | -14.5% | 29,700 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $758,000 | – | 29,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |